Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CBLB | Q13191 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 6/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.33 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3295908 | 1.00 | ALDH1A1 (0.37) | ALDH1A1TSHRUSP2HSD17B10HRH4 | |
| SCHEMBL8775155 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRUSP2HSD17B10PAOX | |
| SCHEMBL8775415 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRUSP2HSD17B10PAOX | |
| SCHEMBL6684833 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRUSP2HSD17B10PAOX | |
| SCHEMBL6684829 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRUSP2HSD17B10PAOX | |
| SCHEMBL6687965 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRUSP2HSD17B10PAOX | |
| SCHEMBL6687967 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRUSP2HSD17B10PAOX | |
| SCHEMBL3670018 | 0.94 | USP2 (0.37) | ALDH1A1TSHRUSP2HSD17B10HRH4 | |
| SCHEMBL36879 | 0.94 | USP2 (0.37) | ALDH1A1TSHRUSP2HSD17B10HRH4 | |
| SCHEMBL33998 | 0.94 | USP2 (0.37) | ALDH1A1TSHRUSP2HSD17B10HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7737237-B2 | Controlled structure copolymer comprising an amphoteric or zwitterionic part | PHODIA CHIMIE (FR) | 2010-06-15 | — | — | US | claimed |
| US-20060217285-A1 | Controlled structure copolymer comprising an amphoteric or zwitterionic part | RHODIA CHIMIE (FR) | 2006-09-28 | — | — | US | claimed |
| EP-0606742-B1 | Bile acid sequestrant | ROHM & HAAS (US) | 1997-11-19 | — | — | EP | claimed |
| EP-0606742-A1 | Bile acid sequestrant | ROHM AND HAAS COMPANY (US) | 1994-07-20 | — | — | EP | claimed |
| EP-4635989-A1 | CONJUGATED-DIENE-BASED POLYMER, CONJUGATED-DIENE-BASED POLYMER COMPOSITION, CROSSLINKED RUBBER OBJECT, AND TIRE | Zeon Corporation (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20250304777-A1 | RUBBER COMPOSITION, RUBBER CROSSLINKED PRODUCT, TIRE, AND RUBBER CROSSLINKED PRODUCT MANUFACTURING METHOD | ZEON CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| US-20250115746-A1 | OIL-EXTENDED CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, CROSSLINKED RUBBER PRODUCT, AND TIRE | ZS ELASTOMERS CO., LTD. (JP) | 2025-04-10 | — | — | US | disclosed |
| EP-4534592-A1 | RUBBER COMPOSITION, RUBBER CROSSLINKED PRODUCT, TIRE, AND RUBBER CROSSLINKED PRODUCT MANUFACTURING METHOD | Zeon Corporation (JP) | 2025-04-09 | — | — | EP | disclosed |
| EP-4471084-A1 | OIL-EXTENDED CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, CROSSLINKED RUBBER PRODUCT, AND TIRE | ZS Elastomers Co., Ltd. (JP) | 2024-12-04 | — | — | EP | disclosed |
| EP-3714007-B1 | ANTIFOULING COMPOSITION | JOTUN AS (NO) | 2024-08-21 | — | — | EP | disclosed |
| US-12024595-B2 | Polymer composition | BASF SE (DE) | 2024-07-02 | — | — | US | disclosed |
| WO-2024070594-A1 | METHOD FOR PRODUCING ELASTOMER PELLETS | ＺＳエラストマー株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20100249249-A1 | Reduction of the Formation of Biofilm by Means of Multifunctional Copolymers | HENKEL AG & CO. KGAA (DE) | 2010-09-30 | — | — | US | disclosed |
| EP-2215134-A2 | REDUCTION OF THE FORMATION OF BIOFILM BY MEANS OF MULTIFUNCTIONAL COPOLYMERS | Henkel AG & Co. KGaA (DE) | 2010-08-11 | — | — | EP | disclosed |
| US-20090238889-A1 | Hyper-Branched Polymers for the Provision of Hygienic Characteristics | HENKEL AG & CO. KGAA (DE) | 2009-09-24 | — | — | US | disclosed |
| WO-2009071451-A2 | REDUCTION OF THE FORMATION OF BIOFILM BY MEANS OF MULTIFUNCTIONAL COPOLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-06-11 | — | — | WO | disclosed |
| EP-2066736-A2 | HYPER-BRANCHED POLYMERS FOR THE PROVISION OF HYGIENIC CHARACTERISTICS | Henkel AG & Co. KGaA (DE) | 2009-06-10 | — | — | EP | disclosed |
| WO-2008037698-A2 | HYPER-BRANCHED POLYMERS FOR THE PROVISION OF HYGIENIC CHARACTERISTICS | HENKEL AG & CO. KGAA (DE) | 2008-04-03 | — | — | WO | disclosed |
| EP-0606742-B1 | Bile acid sequestrant | ROHM & HAAS (US) | 1997-11-19 | — | — | EP | disclosed |
| EP-0606742-A1 | Bile acid sequestrant | ROHM AND HAAS COMPANY (US) | 1994-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249249-A1 | Reduction of the Formation of Biofilm by Means of Multifunctional Copolymers | PGLS, FGB, MUC1 | ALDH1A1 1620/4885TSHR 3217/4885USP2 441/4885 |
| US-20090238889-A1 | Hyper-Branched Polymers for the Provision of Hygienic Characteristics | CD44, PCNA, ITGB3 | ALDH1A1 1449/4885TSHR 3834/4885USP2 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.